Atlanchim Pharma webinar
TosMic: a powerful reagent in the synthesis of heterocycles
🗓️ Thursday, December 7 2023 – 3.00 P.M
Thursday, December 7 2023 - 3.00 P.M
DISCOVER THE PROGRAM OF THIS WEBINAR AND JOIN US!
Tosylmethyl isocyanide (TosMIC), known as van Leusen’s reagent is a powerful and versatile synthon which has become a classical reagent for the construction of 1,3-azoles and pyrroles, as well as fused heterocycles. In this new webinar AtlanChim Pharma, we will illustrate various TosMIC applications through recent examples from medicinal chemistry.
As usual, I will be happy to present this work to you and answer all your questions! We therefore give you an appointment on Thursday, December 7 at 3.00 p.m.
His current research activity concerns the synthesis of biologically active molecules, natural or not, in the fields of cancer, viral pathologies and neurodegenerative diseases, through academic and industrial collaborations. He is also strongly involved in the understanding of biological mechanisms through the synthesis of molecules selectively labeled by non-radioactive isotopes.
Member of the scientific committee of the European Journal of Organic Chemistry (2004-14), Current Organic Synthesis (2004- ) and Molecules, Medicinal Chemistry Section (2020- ).
Member of the National Scientific Research Committee (CNRS – section 12) (2012-2016 and 2017-2022).
Founding partner of the CRO AtlanchimPharma (custom fine chemistry and synthesis of stable isotope labeled molecules) and consultant (since 2004). Professor at the University of Nantes (CEISAM, UMR-CNRS 6513 – Symbiosis group (Multi-step synthesis and bioscience)) Co-author of about 160 publications (h-index 35) and 18 patents (including two with exploitation license and one know-how license), and more than 100 seminars and conferences.